Invention Grant
- Patent Title: Anti-ErbB3 antibodies
- Patent Title (中): 抗ErbB3抗体
-
Application No.: US13082852Application Date: 2011-04-08
-
Publication No.: US08481687B2Publication Date: 2013-07-09
- Inventor: Sylvie Vincent , William M. Winston, Jr. , Fang Wang , Solly Weiler , Kristan Meetze , Lyne Breault , Steve Bottega , Ting Chen , Michael DePrima , Christina Fleet , Steven Tyler , Jin-Kyeung Woo , Jeno Gyuris
- Applicant: Sylvie Vincent , William M. Winston, Jr. , Fang Wang , Solly Weiler , Kristan Meetze , Lyne Breault , Steve Bottega , Ting Chen , Michael DePrima , Christina Fleet , Steven Tyler , Jin-Kyeung Woo , Jeno Gyuris
- Applicant Address: US MA Cambridge
- Assignee: Aveo Pharmaceuticals, Inc.
- Current Assignee: Aveo Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Goodwin Procter LLP
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
Monoclonal antibodies that bind and inhibit activation of epidermal growth factor receptor related member ErbB3/HER3 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation of ErbB3/HER3.
Public/Granted literature
- US20110256154A1 ANTI-ERBB3 ANTIBODIES Public/Granted day:2011-10-20
Information query
